BOSTON SCIENTIFIC CORPORATION Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
BOSTON SCIENTIFIC CORPORATION (BSX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of 1.50% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2026-02-17
- BOSTON SCIENTIFIC CORPORATION effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2024 was 1.50%, a 31.82% decline from fiscal 2023.
- BOSTON SCIENTIFIC CORPORATION effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2023 was 2.20%, a 50.00% decline from fiscal 2022.
- BOSTON SCIENTIFIC CORPORATION effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2022 was 4.40%.
- BOSTON SCIENTIFIC CORPORATION effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2021 was -8.10%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | 1.50% 10-K · filed 2026-02-17 | |
| 2023-12-31 | 2.20% 10-K · filed 2026-02-17 | |
| 2022-12-31 | 4.40% 10-K · filed 2025-02-18 | -4.40% 10-K · filed 2023-02-23 |
| 2021-12-31 | -8.10% 10-K · filed 2024-02-20 | 8.10% 10-K · filed 2022-02-23 |
| 2020-12-31 | -16.70% 10-K · filed 2023-02-23 | 16.70% 10-K · filed 2021-02-23 |
| 2019-12-31 | 12.20% 10-K · filed 2022-02-23 | -12.20% 10-K · filed 2020-02-25 |
| 2018-12-31 | 2.10% 10-K · filed 2021-02-23 | -2.10% 10-K · filed 2019-02-19 |
| 2017-12-31 | 1.70% 10-K · filed 2020-02-25 | 2.10% 10-K · filed 2018-02-20 |
| 2016-12-31 | 11.30% 10-K · filed 2019-02-19 | 9.40% 10-K · filed 2017-02-23 |
| 2015-12-31 | 6.00% 10-K · filed 2018-02-20 | |
| 2014-12-31 | 7.50% 10-K · filed 2017-02-23 | -7.50% 10-K · filed 2015-02-25 |
| 2013-12-31 | 3.50% 10-K · filed 2016-02-24 | |
| 2012-12-31 | 0.00% 10-K · filed 2015-02-25 | |
| 2011-12-31 | -1.90% 10-K · filed 2014-02-26 | |
| 2009-12-31 | 0.50% 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |